Jesús
Bañales Asurmendi
Catedrático de Universidad
University of Tübingen
Tubinga, AlemaniaPublikationen in Zusammenarbeit mit Forschern von University of Tübingen (3)
2024
-
Sensitizing cholangiocarcinoma to chemotherapy by inhibition of the drug-export pump MRP3
Biomedicine and Pharmacotherapy, Vol. 180
-
Stratified analyses refine association between TLR7 rare variants and severe COVID-19
Human Genetics and Genomics Advances, Vol. 5, Núm. 4
2022
-
Bcl-xL as prognostic marker and potential therapeutic target in cholangiocarcinoma
Liver International, Vol. 42, Núm. 12, pp. 2855-2870